Industry Headlines: Page 380

Cannabis Consumer Packaged Goods Brand Going Public, Expanding Global Operations

Denver-based Dixie Brands, Inc. targets going public on the Canadian Securities Exchange in October while planning significant expansion.

Trait Appoints International Marketing Executive, Former Diageo N.A. President and Chief Marketing Officer Peter McDonough to Board of Directors

McDonough has more than 30 years leadership experience across multiple industries, building some of the world’s most iconic consumer brands.

NuLeaf Launches Investment and Entrepreneurial Upskilling for Cannabis Businesses Owned by People of Color in Portland, Ore.

NuLeaf's NuFuel is a grant program for cannabis businesses owned by people of color in Portland.

First Student-Organized Cannabis Conference Aims to Educate the Public About Medical Marijuana

The first Green Wolverine Science Symposium took place Sept. 29 at Michigan's Ross School of Business.

Big Contributions Coming In, But So Far It's to Defeat Medical Marijuana in Utah

New campaign finance disclosures show some big contributions to campaigns to defeat Proposition 2.

Fluence CEO Nick Klase Steps Down

COO David Cohen steps up as new chief executive, Klase to take over Fluence R&D division.

Khiron Life Sciences Corp. Announces Formation of Wellness Business Unit, Launch of Its First CBD Cosmeceutical Brand

The first-to-market strategy establishes a cosmeceutical brand in the fast-growing Latin America skin care sector with CBD-based consumer products.

HollyWeed North Cannabis Inc. Announces Letter of Intent to Acquire Women Grow, LLC

Women Grow provides connections, education and empowerment for aspiring and current cannabis entrepreneurs and business executives.

BioTrackTHC is First Cannabis Seed-to-Sale Firm to Complete Financial Statement Audits

An independent auditor has completed the audit of the company's Annual Financial Statements for the fiscal years ending Dec. 31, 2016 and Dec. 31, 2017.

Canada Signs on to U.S.-Led War on Drugs, DEA Places CBD-Based Drug in Schedule V: Week in Review

This week, the DEA placed Epidiolex, a cannabis-derived drug, in Schedule V, marking the first time any drug derived from marijuana has been rescheduled in the U.S.

FSD Pharma Added to Cannabis ETF

The company stock has a 1.9 percent weighting in Horizons Marijuana Life Sciences Index (HMMJ) ETF.

Passengers May Now Bring Cannabis Into Los Angeles International Airport

Passengers may carry 28.5 grams of flower through LAX for personal consumption.

Previous Page

Page 380 of 655

Next Page